Global Veno-Venous Extracorporeal Life Support Devices Market, By Type (Single-Ventricular Device, Biventricular Device), Application (Femoral Vein, Jugular Vein, Right Atrium, Others), End-User (Hospitals, Clinics, Others) – Industry Trends and Forecast to 2029
Veno-Venous Extracorporeal Life Support Devices Market Analysis and Size
The global veno-venous extracorporeal life support devices market is expected to witness significant growth during the forecast period. An extracorporeal life support system is a form of extracorporeal support. In-vitro life support systems support intensive care of respiratory failure, especially in adult patients. The operating principle of the extracorporeal life-sustaining device is based on an external pump that sends the patient's venous blood to the extracorporeal membrane oxygenator, where the blood is concentrated with oxygen and carbon dioxide is removed. The blood is then returned to the patient's system.
Data Bridge Market Research analyses a growth in the veno-venous extracorporeal life support devices market in the forecast period 2022-2029. The expected CAGR of global veno-venous extracorporeal life support devices market is tend to be around 5.0% in the mentioned forecast period. The market was valued at USD 210.0 million in 2021, and it would grow upto USD 310.27 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Veno-Venous Extracorporeal Life Support Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Single-ventricular Device, Biventricular Device), Application (Femoral vein, Jugular vein, Right atrium, Others), End-User (Hospitals, Clinics, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
AQUETHolding B. V. & Co. KG (Germany), Microport Scientific Corporation (China), Medos Medizintechnik AG (Germany), Sorin Group(Italy), Medtronic (Ireland), Terumo Cardiovascular Systems Corporation (US), and Nipro Medical Corporation (US)
|
|
Market Opportunities
|
|
Market Definition
Extracorporeal Membrane Oxygenation (ECMO), also known as Extracorporeal Membrane Oxygenation (ECMO), provides long-term cardiac and respiratory support for the heart and lungs that are unable to maintain proper gas exchange or proper blood flow. Extracorporeal membrane oxygenation. ECLS technology is derived from heart-lung machine and provides short-term support while the natural circulation is stopped. Venous extracorporeal life support systems (VV ECLS) are observed as demand increases and the incidence and prevalence of cardiopulmonary disease and respiratory failure increase.
Global veno-venous extracorporeal life support devices market Dynamics
Drivers
- Increased Prevalence of CVD
North America dominates much of the global veno-venous extracorporeal life support devices market. Factors According to a report released by WHO in 2015, 17.5 million people die of cardiopulmonary disease, accounting for more than 30% of the world's deaths. Factors contributing to the increased prevalence of cardiopulmonary disease include aging populations, lifestyle changes, increased disposable income, and smoking.
- Rising Elderly Population
Increasing number of elderly population and their associated diseases are acting as a driving force to the expansion of the market.
Opportunities
- Funding For Research and clinical activities
Increasing funding for R&D activities for the treatment of cardiovascular diseases by various regulators and some state governments is also expected to boost the growth of the veno-venous extracorporeal life support devices market.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to use these devices could curb the growth of the global laboratory development test market over a forecast period.
- High Cost
High cost of these life support devices can hinder the growth of the global veno-venous extracorporeal life support devices market even though the prevalence of the diseases are high.
This veno-venous extracorporeal life support devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the veno-venous extracorporeal life support devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Veno-Venous Extracorporeal Life Support Devices Market
Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the forecast period. Our ongoing research is enhancing our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included.
In the post pandemic situation, the use of veno-venous extracorporeal life support devices is still on the rise. There are chances of getting caught with veno-venous extracorporeal complications even after getting therapeutic treatments for COVID-19. Hence, due to this the market has flourished well and is still rising high.
Global Veno-Venous Extracorporeal Life Support Devices Market Scope
The global veno-venous extracorporeal life support devices market is segmented on the basis of type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Single-ventricular Device
- Biventricular Device
Application
- Femoral vein
- Jugular vein
- Right atrium
- Others
End User
- Hospitals
- Clinics
- Others
Veno-Venous Extracorporeal Life Support Devices Market Regional Analysis/Insights
The global veno-venous extracorporeal life support devices market is analysed and market size insights and trends are provided by country, type, application and end-user as referenced above.
The major countries covered in the veno-venous extracorporeal life support devices market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates much of the global veno-venous extracorporeal life support devices market. Factors that make up the dominant part of North America are an increasing elderly population, an increased incidence of cardiopulmonary disease, high demand for innovative products, and government programs to raise awareness of the risks associated with cardiopulmonary disease.
Meanwhile, the Asia-Pacific region has shown significant growth in the veno-venous extracorporeal life support devices market due to the aging population, increasing prevalence of cardiovascular and cardiovascular disease, as well as increased awareness and demand
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Veno-Venous Extracorporeal Life Support Devices Market Share Analysis
The veno-venous extracorporeal life support devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to veno-venous extracorporeal life support devices market.
Key players operating in the veno-venous extracorporeal life support devices market include:
- AQUETHolding B. V. & Co. KG (Germany)
- Microport Scientific Corporation (China)
- Medos Medizintechnik AG (Germany)
- Sorin Group(Italy)
- Medtronic (Ireland)
- Terumo Cardiovascular Systems Corporation (US)
- Nipro Medical Corporation (US)
SKU-